parkinson-s-disease

Documents about parkinson-s-disease

• Safety and Efficacy Study of Fipamezole in Treatment of Motor Dysfunctions in Parkinson's Disease#846853ClinicalTrials.gov
• The Role of EEG in Identifying Cognitive Changes in Parkinson's Disease#824830ClinicalTrials.gov
• Study of Transanal Irrigation vs Standard Care for Constipation, Gut Microbiota, and Motor Disorders in Parkinson's Disease#848699ClinicalTrials.gov
• Ending Parkinson's Disease#466045Open Library
• ANN for Parkinson’s Disease Prediction#764715PhilArchive
• Genetic landscape of Parkinson’s disease in the Personalized Parkinson Project cohort#395174Europe PMC
• The Effect of Simple Gymnastics Training for Parkinson's Patients in the Community#876321ClinicalTrials.gov
• Spike RBD drives sustained Parkinson's disease progression via microglia-neuron crosstalk-mediated RTP801 upregulation#205505Europe PMC
• Axial symptoms as main predictors of short-term subthalamic stimulation outcome in Parkinson's disease#250650IRIS
• Intestinal histomorphological and molecular alterations in patients with Parkinson's disease#304794IRIS
• Deficits in episodic memory and executive functions in relation to CB1 receptor availability in Parkinson's disease#642348Europe PMC
• Differential effects of levodopa on social cognition in people with Parkinson's disease#658860HAL (France)
• Development of a new methodology for quantitative analysis of rigidity in Parkinson’s disease#685082HAL (France)
• An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parkinson's Disease#800930ClinicalTrials.gov
• Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients#803894ClinicalTrials.gov
• A Pharmacodynamics and Safety Study of DSP-9632P in Patients With Levodopa-Induced Dyskinesia in Parkinson's Disease#832546ClinicalTrials.gov
• Continuous Application of Lisuride in Parkinson's Disease by Subcutaneous Infusion#811380ClinicalTrials.gov
• Toward Molecular Profiling of Parkinson's Disease in Easily Accessible Biological Matrices#810909ClinicalTrials.gov
• Monitoring of Mobility of Parkinson's Patients for Therapeutic Purposes - Clinical Trial#868714ClinicalTrials.gov
• Cognitive-driven ADL Impairment as a Predictor for PDD#803237ClinicalTrials.gov
• The Effects of 24-Weeks Community-based Brisk Walking in People With Parkinson's Disease#857465ClinicalTrials.gov
• Diagnostic Potential of Combined Skin Morphometric Analysis and Salivary Alpha-Synuclein Oligomers in Parkinson's Disease#120143Europe PMC
• Assessing Naturalistic Communication in Parkinson’s Disease: A Passive Audio Capture Study#186601OSF
• US-UK Pricing Comparisons of Parkinson’s Disease Therapies#305976ScholarlyCommons at Penn
• Socio-Occupational Functioning after Subthalamic Deep Brain Stimulation in Parkinson's Disease#322676IRIS
• The effects of nicotine on Parkinson's disease: A systematic review and meta-analysis of experimental evidence#676271Europe PMC
• Single-center Pathophysiological Study of the Role of Inflammation, Changes in the Intestinal Epithelial Barrier and the Intestinal Microbiota in Parkinson's Disease#802499ClinicalTrials.gov
• Effect of Osteopathic Manipulative Medicine (OMM) on Pulmonary Function and Speech in Parkinson's Disease#846826ClinicalTrials.gov
• The Role of Cerebellar Hyperactivity in Parkinson's Disease#856521ClinicalTrials.gov
• Effect of 2.5 Years of Rasagiline Therapy on Progression of Cognitive Biomarkers Assessed by MRI in Parkinson's Disease.#879576ClinicalTrials.gov
• Non-invasive Diagnosis of Parkinson's Disease#838464ClinicalTrials.gov
• 42 U.S.C. § 284f — Parkinson’s disease#595168US Code (LII)
• Documented End-of-Life Preferences of People With Parkinson's Disease or Parkinsonism Across Europe.#193896PubMed
• Regional Pain is Associated with Functional Performance in People with Parkinson's Disease#626196ODU Digital Commons
• Evaluation of Safety and Tolerability of Fetal Mesencephalic Dopamine Neuronal Precursor Cells for Parkinson's Disease#812315ClinicalTrials.gov
• An Integrated and Personalized Lifestyle Approach for People With Parkinson's Disease#829111ClinicalTrials.gov
• Split-belt Treadmill Training to Rehabilitate Freezing of Gait and Balance in Parkinson's Disease#841769ClinicalTrials.gov
• Aquatic Therapy for Freezing of Gait in Parkinson's Disease Patients#842467ClinicalTrials.gov
• PARK-FIT. Treadmill vs Cycling in Parkinson´s Disease. Definition of the Most Effective Model in Gait Reeducation#848109ClinicalTrials.gov
• Physical Activity on Neuroinflammation in Parkinson's Disease#854048ClinicalTrials.gov
• Efficacy of Botulinum Toxin for the Treatment of Dystonia Associated With Parkinson's Disease and Atypical Parkinsonism#867232ClinicalTrials.gov
• Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease#874932ClinicalTrials.gov
• Study to Determine Mutations in the Gaucher Gene in Patients With Idiopathic Parkinson's Disease for Phenotype-genotype Correlation#806768ClinicalTrials.gov
• Behavioral Intervention for Lifestyle Physical Activity in Parkinson's Disease#844224ClinicalTrials.gov
• Dopaminergic Identity of SH-SY5Y Cells Across Differentiation Protocols in Parkinson's Disease Research: A Systematic Review#205518Europe PMC
• Bio-inspired Solid Lipid Nanoparticles for therapeutic siRNA delivery targeting the LRRK2 G2019S mutation in a Parkinson’s disease cell model.#215983ResearchSpace
• Shared Spectral Parameters Between EEG and Basal Ganglia LFP Distinguish Sleep-Specific Oscillations in Parkinson's Disease#676421Europe PMC
• Corticostriatal glutamate mechanisms underlying beta synchrony and motor deficits via striatal NMDA receptors in Parkinson's disease#676442Europe PMC
• The Effect of Low Frequency STN DBS on Sleep and Vigilance in Parkinson's Disease (PD) Patients#800460ClinicalTrials.gov
• Support needs of people with younger onset Parkinson's disease: An interpretative phenomenological analysis#824158Research Online